Search results for "artery disease"

showing 10 items of 652 documents

Variables affecting the quality of anticoagulation in atrial fibrillation patients newly initiating vitamin K antagonists: insights from the national…

2021

Abstract Aims Vitamin K antagonists (VKAs) are effective drugs reducing the risk for stroke in atrial fibrillation (AF), but the benefits derived from such therapy depend on the international normalized ratio (INR) maintenance in a narrow therapeutic range. Here, we aimed to determine independent variables driving poor anticoagulation control [defined as a time in therapeutic range (TTR) <65%] in a ‘real world’ national cohort of AF patients. Methods and results The SULTAN registry is a multicentre, prospective study, involving patients with non-valvular AF from 72 cardiology units expert in AF in Spain. At inclusion, all patients naïve for oral anticoagulation were started with VKAs…

Malemedicine.medical_specialtyVitamin K030204 cardiovascular system & hematologyAmiodaroneCoronary artery disease03 medical and health sciences0302 clinical medicinePhysiology (medical)Internal medicineAtrial FibrillationHumansMedicineInternational Normalized RatioProspective StudiesRegistries030212 general & internal medicineProspective cohort studyStrokeAgedAged 80 and overbusiness.industryProportional hazards modelAnticoagulantsAtrial fibrillationOdds ratioMiddle Agedmedicine.diseaseConfidence intervalStrokeFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugEP Europace
researchProduct

Serum 25-hydroxyvitamin D and the incidence of peripheral artery disease in the elderly: The Pro.V.A study

2015

Aim: This study was conducted to examine whether low serum levels of 25-hydroxyvitamin D (250HD) are associated with a higher risk of incident peripheral artery disease (PAD) in a representative group of elderly people. Methods: We followed 1568 community-dwelling elderly participants without PAD at the baseline among a sample of 2097 initially eligible over a mean of 4.4 years as part of the Progetto Veneto Anziani (Pro.V.A.) study. The baseline serum 250HD levels were categorized as <24, 25-49, 50-74, >75 nmol/L, and incident PAD was defined as an ankle-brachial index below 0.9. Results: At the baseline, there were no differences in known risk factors for PAD (BMI), waist circumfere…

Malemedicine.medical_specialtyWaistArterial diseasevitamin DDiseaseperipheral artery diseaseelderlyPeripheral Arterial Diseasecardiovascular diseaseInternal medicineDiabetes mellitusInternal MedicineVitamin D and neurologyMedicineHumansAnkle Brachial IndexSerum 25 hydroxyvitamin dAgedbusiness.industryIncidence (epidemiology)Biochemistry (medical)Hazard ratiomedicine.diseaseRegression AnalysisFemaleCardiology and Cardiovascular Medicinebusiness
researchProduct

The FAST-MI 2005-2010-2015 registries in the light of the COMPASS trial: The COMPASS criteria applied to a post-MI population.

2019

International audience; Background: The COMPASS trial assessed the impact of adding low dose rivaroxaban to aspirin in selected patients (pts). After an acute myocardial infarction (MI), when dual antiplatelet treatment is no longer needed, patients might be eligible for aspirin/rivaroxaban co-therapy. The characteristics and risks of such a population are unclear.Methods: Data were extracted from the FAST-MI 2005, 2010 and 2015 nationwide French registries. Characteristics and long-term mortality were compared according to COMPASS eligibility and between registry and trial populations.Results: Among 9954 patients alive and free of events at one year, 4402 (44%) were classified as COMPASS-L…

Malemedicine.medical_specialtyanimal structuresPopulationMyocardial Infarction030204 cardiovascular system & hematologyCoronary artery diseaselaw.inventionCoronary artery diseaseCohort Studies03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemRandomized controlled trialRivaroxabanlawCompassInternal medicinemedicineHumans030212 general & internal medicineMyocardial infarctionRegistrieseducationAgedAged 80 and overIschemic and hemorrhagic riskAspirinRivaroxabaneducation.field_of_studyAspirinbusiness.industryAnticoagulantsMiddle Agedmedicine.disease[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system3. Good healthIncreased risk[SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/PharmacologyPopulation SurveillanceCOMPASS study[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/PharmacologyFemaleFranceCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation Inhibitorsmedicine.drugFollow-Up StudiesInternational journal of cardiology
researchProduct

Quality-of-Life and Economic Outcomes of Assessing Fractional Flow Reserve With Computed Tomography Angiography: PLATFORM.

2015

International audience; BACKGROUND: Fractional flow reserve estimated using computed tomography (FFRCT) might improve evaluation of patients with chest pain. OBJECTIVES: The authors sought to determine the effect on cost and quality of life (QOL) of using FFRCT instead of usual care to evaluate stable patients with symptoms suspicious for coronary disease. METHODS: Symptomatic patients without known coronary disease were enrolled into 2 strata based on whether invasive or noninvasive diagnostic testing was planned. In each stratum, consecutive observational cohorts were evaluated with either usual care or FFRCT. The number of diagnostic tests, invasive procedures, hospitalizations, and medi…

Malemedicine.medical_specialtycost comparisonVisual analogue scale*Fractional Flow Reserve[SDV]Life Sciences [q-bio]Fractional flow reserveCoronary Artery Disease030204 cardiovascular system & hematologyChest painCoronary Angiography030218 nuclear medicine & medical imagingCoronary artery diseaseAnginaCohort Studiesquality of life03 medical and health sciencesCoronary Artery Disease/*economics/*radiography/therapy0302 clinical medicineQuality of lifeEQ-5DmedicineHumansLongitudinal StudiesProspective StudiesMyocardial/physiologyTomographyComputed tomography angiography*Quality of Lifemedicine.diagnostic_testbusiness.industryX-Ray Computed/*economicsMiddle Agedmedicine.diseaseCoronary Angiography/*economics3. Good healthFractional Flow Reserve MyocardialTreatment OutcomePhysical therapyQuality of Lifestress testFemalemedicine.symptombusinessCardiology and Cardiovascular MedicineTomography X-Ray Computedmyocardial fractional flow reserveJournal of the American College of Cardiology
researchProduct

Orthostatic changes in blood pressure and mortality in the elderly: The Pro.V.A study

2015

BACKGROUND An extensive, albeit contrasting literature has suggested a possible role for orthostatic hypotension as a risk factor for cardiovascular (CVD) and non-CVD mortality, while no data are available for orthostatic hypertension. We investigated whether orthostatic changes in blood pressure (BP) were associated with any increased risk of all-cause, CVD or non-CVD mortality in a group of elderly people. METHODS Two thousand seven hundred and eighty six community-dwelling older participants were followed for 4.4 years. Participants were grouped according to whether they had a drop ≤20mm Hg in systolic, or ≤10mm Hg in diastolic BP (orthostatic hypotension), an increase in mean orthostati…

Malemedicine.medical_specialtyhypertensionelderlyCohort StudiesCoronary artery diseaseorthostatic hypotensionHypotension OrthostaticOrthostatic vital signscardiovascular diseaseInternal medicineInternal MedicinemedicineHumansRisk factorSystoleAgedAged 80 and overorthostatic hypertensionbusiness.industryblood pressureAtrial fibrillationmedicine.diseasemortalityBlood pressureItalyHeart failureCardiologyFemaleOrthostatic hypertensionmedicine.symptombusiness
researchProduct

Risk Factors of Coronary Artery Disease in Secondary Prevention—Results from the AtheroGene—Study

2015

Background Risk factors are important in cardiovascular (CV) medicine for risk stratification of patients. We aimed to compare the traditional risk factors to clinical variables for the prediction of secondary cardiovascular events. Methods and Results For this study, 3229 patients with known coronary artery disease (CAD) were included. We calculated whether the traditional risk factors, diabetes mellitus, increased LDL/HDL ratio, arterial hypertension and smoking alone and in combination with the clinical variables, ejection fraction, creatinine clearance, multi-vessel disease and CRP concentration predict the outcome cardiovascular death or non-fatal myocardial infarction (N = 432) during…

Malemedicine.medical_specialtylcsh:MedicineRenal functionCoronary Artery DiseaseCoronary artery diseaseAnginaCohort StudiesRisk FactorsInternal medicineDiabetes mellitusmedicineSecondary PreventionHumansMyocardial infarctionRisk factorlcsh:ScienceProportional Hazards ModelsMultidisciplinarybusiness.industrylcsh:RHazard ratioMiddle Agedmedicine.diseaseCardiologyRegression Analysislcsh:QFemalebusinessCohort studyResearch ArticleFollow-Up StudiesPLoS ONE
researchProduct

Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the Ath…

2005

Aims Metalloproteinases are proteolytic enzymes, which decompose the extracellular matrix, influence cardiac remodelling, and are inhibited by tissue inhibitor of metalloproteinases (TIMPs). Little is known about the prognostic impact of the TIMP-1/matrix metalloproteinase complex in patients with future cardiovascular death. Methods and results In 1979 patients with suspected coronary artery disease (CAD), TIMP-1 has been determined at baseline. Among 1945 (98.4%) patients with a mean follow-up period of 2.6±1.2 years, 75 patients died because of cardiovascular causes. Mean concentrations of TIMP-1 were higher among patients who experienced a fatal cardiovascular event than among those who…

Malemedicine.medical_specialtymedicine.drug_classDiseaseCoronary Artery DiseaseCoronary artery diseaseRisk FactorsInternal medicinemedicineNatriuretic peptideHumansTissue Inhibitor of Metalloproteinase-1business.industryHazard ratioConfoundingProteolytic enzymesTissue inhibitor of metalloproteinaseMiddle Agedmedicine.diseasePrognosisEndocrinologyCardiovascular DiseasesCirculatory systemCardiologyFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersFollow-Up StudiesEuropean heart journal
researchProduct

Head-to-Head Comparison of the Incremental Predictive Value of The Three Established Risk Markers, Hs-troponin I, C-Reactive Protein, and NT-proBNP, …

2020

Risk stratification among patients with coronary artery disease (CAD) is of considerable interest to potentially guide secondary preventive therapies. Cardiac troponins as well as C-reactive protein (hsCRP) and natriuretic peptides have emerged as biomarkers for risk stratification. The question remains if one of these biomarkers is superior in predicting adverse outcomes. Thus, we perform a head-to-head comparison between high-sensitivity troponin I (hsTnI), hsCRP, and N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with CAD. Plasma levels were measured in a cohort of 2193 patients with documented CAD. The main outcome measures were cardiovascular (CV) death and/or nonfata…

Malemedicine.medical_specialtymedicine.drug_classHead to headMyocardial Infarctionlcsh:QR1-502030204 cardiovascular system & hematologyBiochemistryArticlelcsh:MicrobiologyCoronary artery disease03 medical and health sciences0302 clinical medicineInternal medicineNatriuretic Peptide BrainTroponin ImedicineNatriuretic peptideHumans030212 general & internal medicineMyocardial infarctioncardiovascular diseasesMolecular BiologyAgedbiologybusiness.industryhigh-sensitivity troponin ITroponin IC-reactive proteinHazard ratioMiddle Agedmedicine.diseasePeptide FragmentsN-terminal pro-brain natriuretic peptideC-Reactive ProteinCohortbiology.proteinCardiologyFemalehigh-sensitivity C-reactive proteinprognosisbusinessBiomarkerscoronary artery diseaseFollow-Up StudiesBiomolecules
researchProduct

Ten-year outcome after coronary angioplasty in patients with single-vessel coronary artery disease and comparison with the results of the Coronary Ar…

2000

The 10-year results of randomized trials comparing percutaneous transluminal coronary angioplasty (PTCA) in patients with single-vessel coronary artery disease (CAD) with coronary artery bypass grafting (CABG) and medical treatment are not available yet. The aim of this evaluation was to compare our 10-year follow-up results after PTCA in patients with single-vessel CAD with the 10-year follow-up results after CABG and medical treatment in the Coronary Artery Surgery Study (CASS) trial. We evaluated the clinical outcome of 509 patients with single-vessel CAD 10 years after coronary angioplasty. The data were compared with the results of 214 patients with single-vessel CAD after CABG or medi…

Malemedicine.medical_specialtymedicine.medical_treatmentAdrenergic beta-AntagonistsCoronary DiseaseBalloonDisease-Free Survivallaw.inventionCoronary artery diseaseNitroglycerinRandomized controlled triallawAngioplastyInternal medicineGermanySurveys and QuestionnairesmedicineHumanscardiovascular diseasesMyocardial infarctionDerivationAngioplasty Balloon CoronaryCoronary Artery BypassHypolipidemic Agentsbusiness.industryAnticoagulantsMiddle Agedmedicine.diseaseCalcium Channel BlockersSurvival AnalysisSurgerysurgical procedures operativemedicine.anatomical_structureTreatment OutcomeBypass surgeryCardiologyFemaleCardiology and Cardiovascular MedicinebusinessArteryFollow-Up StudiesThe American journal of cardiology
researchProduct

Peripheral atherosclerosis is associated with the occurrence of restenosis after percutaneous coronary intervention

2007

The aim of our study was to evaluate, in patients with proven coronary artery disease (CAD) and treated with elective percutaneous coronary intervention (PCI), whether the coexistence of asymptomatic carotid and femoral atherosclerotic lesions would provide prognostic information in terms of occurrence of restenosis.We studied 104 patients with CAD (M/F=77/27), mean age 60.5+/-9 years. All patients were treated with elective PCI. After PCI the suspicion of restenosis was confirmed by coronary angiography. All patients underwent ultrasound duplex scan of carotid and femoral-popliteal-tibial axis to detect atherosclerotic lesions. According to ultrasound results, patients were classified as n…

Malemedicine.medical_specialtymedicine.medical_treatmentBalloonAsymptomaticPeripheral atherosclerosispercutaneous coronary interventionCoronary RestenosisCoronary artery diseaseRestenosisInternal medicineAngioplastymedicineHumanscardiovascular diseasesAngioplasty Balloon CoronaryAgedPeripheral Vascular Diseasesbusiness.industryPercutaneous coronary interventionGeneral MedicineMiddle AgedAtherosclerosisPrognosismedicine.diseasePeripheralConventional PCICardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessCoronary Artery Disease
researchProduct